Document Detail


Second-trimester induction of labor.
MedLine Citation:
PMID:  19407525     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Second-trimester abortions are most commonly performed in the United States via dilation and evacuation; however, there are instances in which the use of systemic abortifacients is necessary. Lack of trained staff to perform late abortion procedures, fetal anomalies, and patient preference are important considerations when selecting the method of termination. Second-trimester abortions with misoprostol-only protocols require higher doses, side effects are more common, and the time to complete the abortion is longer in comparison to mifepristone-misoprostol combinations. Feticidal agents are recommended to avoid transient fetal survival. This chapter will review medical induction methods between gestational ages of 14 and 24 weeks that are commonly used in the United States.
Authors:
Juan Vargas; Justin Diedrich
Related Documents :
7468705 - Factors influencing morbidity in termination of pregnancy.
7446625 - Surgery during pregnancy and fetal outcome.
3867655 - Continuous extraovular prostaglandin f2 alpha instillation for second-trimester pregnan...
7156025 - Ultrasonic placental localization in relation to spontaneous abortion after mid-trimest...
18060945 - Relationship between follicle number and (multiple) live birth rate after controlled ov...
16923695 - A cardiovascular profile score in the surveillance of fetal hydrops.
Publication Detail:
Type:  Journal Article; Review    
Journal Detail:
Title:  Clinical obstetrics and gynecology     Volume:  52     ISSN:  1532-5520     ISO Abbreviation:  Clin Obstet Gynecol     Publication Date:  2009 Jun 
Date Detail:
Created Date:  2009-05-01     Completed Date:  2009-07-24     Revised Date:  2009-11-11    
Medline Journal Info:
Nlm Unique ID:  0070014     Medline TA:  Clin Obstet Gynecol     Country:  United States    
Other Details:
Languages:  eng     Pagination:  188-97     Citation Subset:  IM    
Affiliation:
Department of Obstetrics, Gynecology and Reproductive Sciences, University of California, San Francisco, CA 94110, USA. vargasj@obgyn.ucsf.edu
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Abortifacient Agents, Nonsteroidal / administration & dosage,  adverse effects
Abortion, Induced / adverse effects,  methods*,  mortality
Administration, Intravaginal
Dilatation
Drug Therapy, Combination
Female
Gynecologic Surgical Procedures
Humans
Maternal Mortality
Mifepristone / administration & dosage
Misoprostol / administration & dosage,  adverse effects
Pain, Postoperative / prevention & control
Pregnancy
Pregnancy Trimester, Second
Chemical
Reg. No./Substance:
0/Abortifacient Agents, Nonsteroidal; 59122-46-2/Misoprostol; 84371-65-3/Mifepristone

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Second-trimester surgical abortion.
Next Document:  Infectious complications of pregnancy termination.